HomeProductsKey IntermediatesLeukemia Bosutinib Antineoplastic CAS 380843-75-4 SKI-606

Leukemia Bosutinib Antineoplastic CAS 380843-75-4 SKI-606

$880 - 960 /Kilogram
1 /Kilogram (Min. Order)
option:
Payment Type:
T/T
Incoterm:
FOB,CIF,Express Delivery
Min. Order:
1 Kilogram
Transportation:
Ocean,Land,Air,Express
Port:
Shenzhen,Shanghai,Hongkong
Share:
Chat Now
  • Product Description
Overview
Product Attributes

Model No.Bosutinib

BrandRhine

Shelf Life2years

Test MethodHPLC

PackagingFoil Bag Drum

Grade StandardMedical Grade

Characteristicwhite powder

Assay99%

CAS380843-75-4

Product NameBosutinib

MFC26H29Cl2N5O3

MW530.45

Supply Ability & Additional Information

PackagingFoil Bag Drum

Productivity50kg/month

TransportationOcean,Land,Air,Express

Place of Originchina

Supply Ability50kg/month

CertificateN/A

HS Code/

PortShenzhen,Shanghai,Hongkong

Payment TypeT/T

IncotermFOB,CIF,Express Delivery

Packaging & Delivery
Selling Units:
Kilogram
Package Type:
Foil Bag Drum
Bosutinib is a synthetic quinolone derivative and dual kinase inhibitor that targets both Abl and Src kinases with potential antineoplastic activity. Unlike imatinib, bosutinib inhibits the autophosphorylation of both Abl and Src kinases, resulting in inhibition of cell growth and apoptosis. Because of the dual mechanism of action, this agent may have activity in resistant CML disease, other myeloid malignancies and solid tumors. Abl kinase is upregulated in the presence of the abnormal...

Product Categories : Key Intermediates

Email to this supplier
  • *Subject:
  • *To:
    Ms. Caroline
  • *Email:
  • *Message:
    Your message must be between 20-8000 characters
Send Inquiry
*
*

HomeProductsKey IntermediatesLeukemia Bosutinib Antineoplastic CAS 380843-75-4 SKI-606
Related Products List

Home

Product

Whatsapp

About Us

Inquiry

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send